Efient prasugrel regulatory update

The U.K.’s NICE published final guidance recommending the use of Efient prasugrel from Eli Lilly in combination with aspirin to prevent atherothrombotic events in adults with acute coronary syndrome (ACS) or ST-segment elevation myocardial infarction (STEMI) having primary or delayed percutaneous coronary intervention (PCI) - its approved indication. The final guidance is in line with updated draft guidance published in June (see BioCentury, June 30). ...